Prediction Model of Long-term Survival After Esophageal Cancer Surgery

被引:14
|
作者
Xie, Shao-Hua [1 ]
Santoni, Giola [1 ]
Malberg, Kalle [1 ]
Lagergren, Pernilla [1 ,2 ]
Lagergren, Jesper [1 ,3 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England
[3] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England
基金
瑞典研究理事会;
关键词
esophageal neoplasms; mortality; prediction model; prognosis; surgery; survival; NEOADJUVANT CHEMORADIOTHERAPY; IMPACT; ADENOCARCINOMA; CHEMOTHERAPY; BENEFIT; RECURRENCE; EXPRESSION; MORBIDITY; CARCINOMA; NOMOGRAM;
D O I
10.1097/SLA.0000000000003431
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: We aimed to develop prediction models for estimating the long-term survival in patients who have undergone surgery for esophageal cancer. Background: Few prediction models have been developed for the long-term survival in esophageal cancer patients. Methods: This nationwide Swedish population-based cohort study included 1542 patients who survived for >= 90 days after esophageal cancer surgery between 1987 and 2010, with follow-up until 2016. Risk prediction models for 1-, 3-, and 5-year all-cause mortality and 3- and 5-year disease-specific mortality were developed using logistic regression. Candidate predictors were established and readily identifiable prognostic factors. The performance of the models was assessed by the area under receiver-operating characteristic curve (AUC) with interquartile range (IQR) using bootstrap cross-validation and risk calibration. Results: Predictors included in all models were age, sex, pathological tumor stage, tumor histology, and resection margin status. The models also included various additional predictors depending on the outcome, that is, education level, neoadjuvant therapy, reoperation (within 30 d of primary surgery) and comorbidity (Charlson comorbidity index). The AUC statistics after cross-validation were 0.71 (IQR 0.69-0.74) for 1-year, 0.77 (IQR 0.75-0.80) for 3-year, and 0.78 (IQR 0.76-0.81) for 5-year all-cause mortality. The corresponding values were 0.76 (IQR 0.74-0.79) for 3-year and 0.77 (IQR 0.71-0.83) for 5-year disease-specific mortality. All models showed good agreement between the observed and predicted risks. Conclusions: These models showed good performance for predicting long-term survival after esophageal cancer surgery and may thus be useful for patients in planning their lives and to guide the postoperative treatment and follow-up.
引用
收藏
页码:933 / 939
页数:7
相关论文
共 50 条
  • [1] Impact of hospital volume on long-term survival after esophageal cancer surgery
    Rouvelas, Ioannis
    Lindblad, Mats
    Zeng, Wenyi
    Viklund, Pernilla
    Ye, Weimin
    Lagergren, Jesper
    [J]. ARCHIVES OF SURGERY, 2007, 142 (02) : 113 - 117
  • [2] SURGERY FOR METASTATIC ESOPHAGEAL CANCER: IS LONG-TERM SURVIVAL FEASIBLE?
    Gunder, Meredith A.
    Rubio, Gustavo A.
    Tiesi, Gregory
    Franceschi, Dido
    Livingstone, Alan S.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1261 - S1261
  • [3] Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer
    Van Daele, Elke
    Scuderi, Vincenzo
    Pape, Eva
    Van De Putte, Dirk
    Varin, Oswald
    Van Nieuwenhove, Yves
    Ceelen, Wim
    Troisi, Roberto
    Pattyn, Piet
    [J]. ACTA CHIRURGICA BELGICA, 2018, 118 (04) : 227 - 232
  • [4] LONG-TERM SURVIVAL AFTER PHOTODYNAMIC THERAPY FOR ESOPHAGEAL CANCER
    SIBILLE, A
    LAMBERT, R
    SOUQUET, JC
    SABBEN, G
    DESCOS, F
    [J]. GASTROENTEROLOGY, 1995, 108 (02) : 337 - 344
  • [5] Long-term survival after pancreatic cancer surgery
    Merlo, Ignacio G.
    Fratantoni, Eugenia
    De Santibanes, Martin
    Ardiles, Victoria
    Sanchez Claria, Rodrigo
    Pekolj, Juan
    De Santibanes, Eduardo
    Mazza, Oscar
    [J]. MEDICINA-BUENOS AIRES, 2021, 81 (05) : 800 - 807
  • [6] Long-term Survival after Gastric Cancer Surgery
    Choi, K. H.
    Shin, Y. M.
    Chang, H. K.
    [J]. 9TH INTERNATIONAL GASTRIC CANCER CONGRESS (IGCC 2011): A GATE TO THE FUTURE OF GASTRIC CANCER TREATMENT, 2011, : 107 - 108
  • [7] Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer
    M Gusella
    S Giacopuzzi
    L Bertolaso
    A Zanoni
    E Pezzolo
    Y Modena
    D Menon
    P Paganin
    J Weindelmayer
    G Crepaldi
    G De Manzoni
    F Pasini
    [J]. The Pharmacogenomics Journal, 2017, 17 : 252 - 257
  • [8] Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer
    Gusella, M.
    Giacopuzzi, S.
    Bertolaso, L.
    Zanoni, A.
    Pezzolo, E.
    Modena, Y.
    Menon, D.
    Paganin, P.
    Weindelmayer, J.
    Crepaldi, G.
    De Manzoni, G.
    Pasini, F.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (03): : 252 - 257
  • [9] Impact of hospital volume on long-term survival after esophageal cancer surgery - Invited critique
    Heitmiller, Richard F.
    [J]. ARCHIVES OF SURGERY, 2007, 142 (02) : 118 - 118
  • [10] Surgery for Early Esophageal Cancer: Operative Outcome and Long-Term Survival
    Bard, Vyacheslav
    Stein, Michael
    Menasherov, Nikolai
    Kashtan, Hanoch
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S1085 - S1085